comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 10:00:58 - browse：23

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： STAT Virtual Event: How to Increase Diversity in Clinical Trials

hotspot

WSS

Diversifying clinical trials isn't enough to close racial gaps: study

Medtronic CEO on promising devices for diabetes, hypertension

How the Dana

How the Dana

Paxlovid should be available without a positive Covid test

STAT Virtual Event: How to Increase Diversity in Clinical Trials

entertainment

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Walensky prepares to leave CDC — and Congress — behind

Did you have Obamacare on your GOP debate bingo card?

Psychedelics group wrestles with new pharma identity

Mindstrong's demise and the future of mental health care

Supreme Court strikes down use of affirmative action

Maker of FluMist seeks to allow at

Affirmative action in medical school literally saved lives

Testing for cancer recurrence creates a new limbo for patients

Continuity nursing helped my family in our darkest PICU moments

The FDA weighs the risks of candy

entertainment

Readout Newsletter: XBI biotech index, Akero Therapeutics

Cassava reveals details — and problems — with Alzheimer's study

Senator probes 340B programs at Cleveland Clinic, Bon Secours

CDC recommends rationing of RSV shot due to shortages

After a drawn out lobbying fight, ARPA

Senator probes 340B programs at Cleveland Clinic, Bon Secours

explore

hotspot

hotspot

Wikipedia